Teva’s long-lasting schizophrenia injectable shines in Phase III

Submitted by admin on November 4, 2024 - 7:02pm

Source:

Clinical Trials Arena

News Tags:

Headline:

snippet:

Data presented at Psych Congress 2024 showed improvements in social functioning and quality of life over an eight-week treatment period.

Search form